Further studies have shown that MYO18B expression is reduced in various cancers, including primary ovarian and colorectal carcinoma, and restoration of MYO18B expression in pleural mesothelioma cell lines decreased tumor growth and metastatic potential. The gene discussed is MYO18B; the disease is neoplasm.